Published in Cancer Sci on October 27, 2009
Nestin and other putative cancer stem cell markers in pancreatic cancer. Med Mol Morphol (2012) 2.21
Nestin in gastrointestinal and other cancers: effects on cells and tumor angiogenesis. World J Gastroenterol (2011) 1.16
Chromosomal aberrations in bladder cancer: fresh versus formalin fixed paraffin embedded tissue and targeted FISH versus wide microarray-based CGH analysis. PLoS One (2011) 0.99
Nuclear localization of COX-2 in relation to the expression of stemness markers in urinary bladder cancer. Mediators Inflamm (2012) 0.95
MAGE-A3 is highly expressed in a cancer stem cell-like side population of bladder cancer cells. Int J Clin Exp Pathol (2014) 0.89
A modified method for isolation of bladder cancer stem cells from a MB49 murine cell line. BMC Urol (2013) 0.88
Delineating the cytogenomic and epigenomic landscapes of glioma stem cell lines. PLoS One (2013) 0.85
A rare fraction of drug-resistant follicular lymphoma cancer stem cells interacts with follicular dendritic cells to maintain tumourigenic potential. Br J Haematol (2012) 0.83
Nestin is an independent predictor of cancer-specific survival after radical cystectomy in patients with urothelial carcinoma of the bladder. PLoS One (2014) 0.83
Functional and molecular characterization of cancer stem-like cells in bladder cancer: a potential signature for muscle-invasive tumors. Oncotarget (2015) 0.83
Side population in human non-muscle invasive bladder cancer enriches for cancer stem cells that are maintained by MAPK signalling. PLoS One (2012) 0.83
Chromosomal imbalances in human bladder urothelial carcinoma: similarities and differences between biopsy samples and cancer stem-like cells. BMC Cancer (2014) 0.83
Differentially expressed genes and microRNAs in bladder carcinoma cell line 5637 and T24 detected by RNA sequencing. Int J Clin Exp Pathol (2015) 0.82
Targeting of alpha-v integrins reduces malignancy of bladder carcinoma. PLoS One (2014) 0.81
Association of the intermediate filament nestin with cancer stage: a meta-analysis based on 223 positive/high nestin cases and 460 negative/low case-free controls. Oncotarget (2015) 0.81
The androgen receptor and stem cell pathways in prostate and bladder cancers (review). Int J Oncol (2011) 0.81
DNA copy number alterations and PPARG amplification in a patient with multifocal bladder urothelial carcinoma. BMC Res Notes (2012) 0.79
Dendritic Cell-Based Immunotherapy Treatment for Glioblastoma Multiforme. Biomed Res Int (2015) 0.78
Expression and role of nestin in human cervical intraepithelial neoplasia and cervical cancer. Int J Oncol (2012) 0.78
Using Copy Number Alterations to Identify New Therapeutic Targets for Bladder Carcinoma. Int J Mol Sci (2016) 0.76
Bladder Cancer Stem-Like Cells: Their Origin and Therapeutic Perspectives. Int J Mol Sci (2015) 0.75
The relationship of cancer stem cells in urological cancers. Cent European J Urol (2013) 0.75
Epithelial plasticity in urothelial carcinoma: Current advancements and future challenges. World J Stem Cells (2016) 0.75
Identification of hMex-3A and its effect on human bladder cancer cell proliferation. Oncotarget (2017) 0.75
Integration of 3D digital mammography with tomosynthesis for population breast-cancer screening (STORM): a prospective comparison study. Lancet Oncol (2013) 2.52
Mitochondrial biogenesis by NO yields functionally active mitochondria in mammals. Proc Natl Acad Sci U S A (2004) 2.44
SOX3 is required during the formation of the hypothalamo-pituitary axis. Nat Genet (2004) 1.99
Surgical treatment of metastatic tumors to the pancreas: a single center experience and review of the literature. World J Surg (2006) 1.77
Impaired generation of mature neurons by neural stem cells from hypomorphic Sox2 mutants. Development (2008) 1.58
Bortezomib-induced peripheral neurotoxicity: a neurophysiological and pathological study in the rat. Exp Neurol (2007) 1.54
Cytogenetic and molecular evaluation of 241 small supernumerary marker chromosomes: cooperative study of 19 Italian laboratories. Genet Med (2005) 1.53
Inflammatory and alternatively activated human macrophages attract vessel-associated stem cells, relying on separate HMGB1- and MMP-9-dependent pathways. J Leukoc Biol (2009) 1.51
Crizotinib in advanced, chemoresistant anaplastic lymphoma kinase-positive lymphoma patients. J Natl Cancer Inst (2014) 1.46
Paclitaxel and Cisplatin-induced neurotoxicity: a protective role of acetyl-L-carnitine. Clin Cancer Res (2003) 1.45
Maternal polymorphisms for methyltetrahydrofolate reductase and methionine synthetase reductase and risk of children with Down syndrome. Am J Obstet Gynecol (2009) 1.42
Complete repair of dystrophic skeletal muscle by mesoangioblasts with enhanced migration ability. J Cell Biol (2006) 1.40
Polarization dictates iron handling by inflammatory and alternatively activated macrophages. Haematologica (2010) 1.36
Junctional adhesion molecule-A-deficient polymorphonuclear cells show reduced diapedesis in peritonitis and heart ischemia-reperfusion injury. Proc Natl Acad Sci U S A (2005) 1.33
A balanced chromosomal translocation disrupting ARHGEF9 is associated with epilepsy, anxiety, aggression, and mental retardation. Hum Mutat (2009) 1.32
Treatment of unruptured cerebral aneurysms by embolization with guglielmi detachable coils: case-fatality, morbidity, and effectiveness in preventing bleeding--a systematic review of the literature. Neurosurgery (2004) 1.32
Pax3:Foxc2 reciprocal repression in the somite modulates muscular versus vascular cell fate choice in multipotent progenitors. Dev Cell (2009) 1.31
De novo balanced chromosome rearrangements in prenatal diagnosis. Prenat Diagn (2009) 1.29
Surgical treatment of intrathyroid metastases: preliminary results of a multicentric study. Anticancer Res (2008) 1.28
Retracted Follistatin induction by nitric oxide through cyclic GMP: a tightly regulated signaling pathway that controls myoblast fusion. J Cell Biol (2006) 1.25
Long-term outcome and prognostic factors of juvenile dermatomyositis: a multinational, multicenter study of 490 patients. Arthritis Care Res (Hoboken) (2010) 1.23
Multimodal quantal release at individual hippocampal synapses: evidence for no lateral inhibition. J Neurosci (2002) 1.18
Partial duplication of the PARK2 gene in a child with developmental delay and her normal mother: a second report. Am J Med Genet B Neuropsychiatr Genet (2013) 1.16
Mutations in CYP2U1, DDHD2 and GBA2 genes are rare causes of complicated forms of hereditary spastic paraparesis. J Neurol (2013) 1.16
From cytogenomic to epigenomic profiles: monitoring the biologic behavior of in vitro cultured human bone marrow mesenchymal stem cells. Stem Cell Res Ther (2012) 1.12
Necdin mediates skeletal muscle regeneration by promoting myoblast survival and differentiation. J Cell Biol (2007) 1.08
Retinoic acid-induced neuritogenesis of human neuroblastoma SH-SY5Y cells is ERK independent and PKC dependent. J Neurosci Res (2004) 1.08
The plasmablasts in Castleman disease. Am J Clin Pathol (2013) 1.07
Melanoma metastatic to the gallbladder and small bowel: report of a case and review of the literature. Melanoma Res (2004) 1.05
Long-term survival of human neural stem cells in the ischemic rat brain upon transient immunosuppression. PLoS One (2010) 1.05
Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals. Clin Infect Dis (2005) 1.04
Monitoring the genomic stability of in vitro cultured rat bone-marrow-derived mesenchymal stem cells. Chromosome Res (2009) 1.03
High-mobility group box 1 release and redox regulation accompany regeneration and remodeling of skeletal muscle. Antioxid Redox Signal (2011) 1.03
TGFbeta/BMP activate the smooth muscle/bone differentiation programs in mesoangioblasts. J Cell Sci (2004) 1.03
Ex vivo treatment with nitric oxide increases mesoangioblast therapeutic efficacy in muscular dystrophy. J Cell Sci (2006) 1.02
The low-affinity receptor for neurotrophins p75NTR plays a key role for satellite cell function in muscle repair acting via RhoA. Mol Biol Cell (2009) 1.02
Requirement of inducible nitric oxide synthase for skeletal muscle regeneration after acute damage. J Immunol (2013) 1.01
Autosomal dominant nocturnal frontal lobe epilepsy--a critical overview. J Neurol (2004) 1.01
Multi-transgenic pigs expressing three fluorescent proteins produced with high efficiency by sperm mediated gene transfer. Mol Reprod Dev (2005) 1.00
Sphingosine 1-phosphate mediates proliferation and survival of mesoangioblasts. Stem Cells (2007) 1.00
Nitric oxide sustains long-term skeletal muscle regeneration by regulating fate of satellite cells via signaling pathways requiring Vangl2 and cyclic GMP. Stem Cells (2012) 1.00
Chromosomal aberrations in bladder cancer: fresh versus formalin fixed paraffin embedded tissue and targeted FISH versus wide microarray-based CGH analysis. PLoS One (2011) 0.99
Hepatic resection using a bipolar vessel sealing device: technical and histological analysis. HPB (Oxford) (2007) 0.98
A new function of microtubule-associated protein tau: involvement in chromosome stability. Cell Cycle (2008) 0.98
Development and validation of a preliminary definition of minimal disease activity in patients with juvenile idiopathic arthritis. Arthritis Rheum (2008) 0.98
Role of MAPKs in platinum-induced neuronal apoptosis. Neurotoxicology (2009) 0.97
ERK1 and ERK2 are involved in recruitment and maturation of human mesenchymal stem cells induced to adipogenic differentiation. J Mol Cell Biol (2011) 0.96
GM3 synthase overexpression results in reduced cell motility and in caveolin-1 upregulation in human ovarian carcinoma cells. Glycobiology (2009) 0.96
Pancreaticoduodenectomy for pancreatic metastases from breast carcinoma. JOP (2004) 0.96
Monitoring techniques for prevention of procedure-related ischemic damage in aneurysm surgery. World Neurosurg (2011) 0.95
Activation of the Y1 receptor by neuropeptide Y regulates the growth of prostate cancer cells. Endocrinology (2005) 0.95
Nitric oxide donor and non steroidal anti inflammatory drugs as a therapy for muscular dystrophies: evidence from a safety study with pilot efficacy measures in adult dystrophic patients. Pharmacol Res (2012) 0.94
ERG deregulation induces PIM1 over-expression and aneuploidy in prostate epithelial cells. PLoS One (2011) 0.93
Lingual vascular canals of the mandible: the risk of bleeding complications during implant procedures. Implant Dent (2007) 0.93
Co-administration of ibuprofen and nitric oxide is an effective experimental therapy for muscular dystrophy, with immediate applicability to humans. Br J Pharmacol (2010) 0.92
Human cardiac mesoangioblasts isolated from hypertrophic cardiomyopathies are greatly reduced in proliferation and differentiation potency. Cardiovasc Res (2009) 0.92
A dual acting compound releasing nitric oxide (NO) and ibuprofen, NCX 320, shows significant therapeutic effects in a mouse model of muscular dystrophy. Pharmacol Res (2011) 0.91
Skeletal muscle differentiation of embryonic mesoangioblasts requires pax3 activity. Stem Cells (2009) 0.91
A rescuable folding defective Nav1.1 (SCN1A) sodium channel mutant causes GEFS+: common mechanism in Nav1.1 related epilepsies? Hum Mutat (2009) 0.91
TGFbeta protects mesoangioblasts from apoptosis via sphingosine kinase-1 regulation. Cell Signal (2008) 0.90
Change in glucose metabolism measured by 18F-FDG PET/CT as a predictor of histopathologic response to neoadjuvant treatment in rectal cancer. Abdom Imaging (2011) 0.90
Revaluation of clinical and histological criteria for diagnosis of dysmetabolic iron overload syndrome. World J Gastroenterol (2008) 0.90
DNA Methylation Changes during In Vitro Propagation of Human Mesenchymal Stem Cells: Implications for Their Genomic Stability? Stem Cells Int (2013) 0.90
Mapping of candidate region for chordoma development to 1p36.13 by LOH analysis. Int J Cancer (2003) 0.89
Neurotoxicity of platinum compounds: comparison of the effects of cisplatin and oxaliplatin on the human neuroblastoma cell line SH-SY5Y. J Neurooncol (2004) 0.89
Human mesenchymal stem cells express neuronal markers after osteogenic and adipogenic differentiation. Cell Mol Biol Lett (2013) 0.89
HuR and miR-1192 regulate myogenesis by modulating the translation of HMGB1 mRNA. Nat Commun (2013) 0.88
NGF protects dorsal root ganglion neurons from oxaliplatin by modulating JNK/Sapk and ERK1/2. Neurosci Lett (2010) 0.88
Effect of the chronic combined administration of cisplatin and paclitaxel in a rat model of peripheral neurotoxicity. Eur J Cancer (2008) 0.88
Mesenchymal stem cells neuronal differentiation ability: a real perspective for nervous system repair? Curr Stem Cell Res Ther (2011) 0.88
Case report of a hepatic angiomyolipoma. Tumori (2004) 0.88
Expression and distribution of 'high affinity' glutamate transporters GLT1, GLAST, EAAC1 and of GCPII in the rat peripheral nervous system. J Anat (2008) 0.88
Paclitaxel toxicity in post-mitotic dorsal root ganglion (DRG) cells. Anticancer Res (2006) 0.88
Adult mesenchymal stem cells rescue dorsal root ganglia neurons from dying. Brain Res (2006) 0.88
Accuracy of ultrasound in the detection of liver fibrosis in chronic viral hepatitis. Radiol Med (2005) 0.88
A glycosphingolipid/caveolin-1 signaling complex inhibits motility of human ovarian carcinoma cells. J Biol Chem (2011) 0.87
Acute portal venous injury after microwave ablation in an in vivo porcine model: a rare possible complication. J Vasc Interv Radiol (2011) 0.87
Necdin is expressed in cachectic skeletal muscle to protect fibers from tumor-induced wasting. J Cell Sci (2009) 0.87
Cytogenetics of premature ovarian failure: an investigation on 269 affected women. J Biomed Biotechnol (2011) 0.87
Correlation between postoperative infections and long-term survival after colorectal resection for cancer. Tumori (2005) 0.86
Fibrosis is associated with adiponectin resistance in chronic hepatitis C virus infection. Eur J Clin Invest (2011) 0.86
Emerging role of mitogen-activated protein kinases in peripheral neuropathies. J Peripher Nerv Syst (2007) 0.86
Expression of neural markers by undifferentiated rat mesenchymal stem cells. J Biomed Biotechnol (2012) 0.85